Evolus to Participate in Three Upcoming Investor Conferences

NEWPORT BEACH, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of management will be participating in three upcoming virtual investor conferences.

Event:	Wells Fargo 2020 Virtual Healthcare Conference
Format:	Virtual Fireside chat
Date:	Thursday, September 10, 2020
Time:	1:20 – 1:50pm ET
Event:	H.C. Wainwright 22nd Annual Global Investment Conference
Format:	Virtual Fireside chat
Date:	Tuesday, September 15, 2020
Time:	12:30 – 12:50pm ET
Event:	Cantor 2020 Virtual Global Healthcare Conference
Format:	Virtual Fireside chat
Date:	Thursday, September 17, 2020
Time:	11:20 – 11:50am ET

An audio webcast of Evolus’ presentation will be available on the investor relations section of Evolus’ website at investors.evolus.com. Replays of the webcasts will be available for 90 days after the date of the presentation.

About Evolus, Inc.

Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. In 2019, the U.S. Food and Drug Administration approved Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure™ technology. Jeuveau® is powered by Evolus' unique technology platform and is designed to transform the aesthetic market by eliminating the friction points existing for customers today. Visit us at: www.evolus.com.

Jeuveau® is a registered trademark of Evolus, Inc.

Hi-Pure™ is a trademark of Daewoong Pharmaceutical Co, Ltd.

Evolus, Inc. Contacts:

Investor Contact:Ashwin Agarwal, Evolus, Inc.Vice President, Finance, Investor Relations & TreasuryTel: +1-949-284-4559Email: [email protected]

Media Contact:Crystal Muilenburg, Evolus, Inc.Vice President, Corporate Communications & Public RelationsTel: +1-949-284-4506Email: [email protected]

 

Source: Evolus

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Icelandic Salmon - Invitation to presentation of the second quarter 2026 results
• Transaction in Own Shares
• Dimensional Fund Advisors Ltd. : Form 8.3 - PROLOGIS INC - Ordinary Shares